PHARMAPACE
LIVE

Serial Number

86292698

Owner

Pharmapace, Inc.

Attorney

Victoria Newland

First Use Date

May 7, 2014

Filing Date

May 27, 2014

Add to watchlist:

No watchlists yet
View on USPTO

PHARMAPACE Trademark

Serial Number: 86292698 • Registration: 4666992

PHARMAPACE is a trademark filed by Pharmapace, Inc. on May 27, 2014. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Pharmapace, Inc.

SUITE 102
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 27, 2014

Registration Date

January 6, 2015

First Use Anywhere

May 7, 2014

First Use in Commerce

May 7, 2014

Published for Opposition

October 21, 2014

Goods & Services

Business advisory services in the field of medical and clinical safety; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business management and consultation in the field of clinical trials; Business management consultation in the field of regulatory submissions; Business management consulting and advisory services for the biotechnology and pharmaceutical industry; Business management consulting services in the field of drug development; Business management consulting, strategic planning and business advisory services provided to companies developing new drugs or medical devices or companies conducting clinical trials; Collection and analysis of quality metric data for clinical trial analysis for business purposes; Compilation of statistics; Compiling and analyzing statistics, data and other sources of information for business purposes; Offering business management assistance in the establishment and/or operation of clinical trials; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Providing statistical information; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Statistical analysis and reporting services for business purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 4, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 4, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 4, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 4, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 17, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 6, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 5, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 5, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 1, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 10, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 6, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 5, 2019 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 21, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 21, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2014 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2014 CNSA
ASSIGNED TO EXAMINER
Sep 9, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2014 NWOS
NEW APPLICATION ENTERED
May 30, 2014 NWAP